Unclaimed brand
Codagenix is combining codon deoptimization with live-attenuated viruses for a vaccine and therapeutic platform poised to transform global health.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#2E61A3
Azure
46, 97, 163
214, 56, 41
72, 40, 0, 36
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#000000
Black
0, 0, 0
0, 0, 0
0, 0, 0, 100
Codagenix, Inc. is a biotechnology company developing vaccine and therapeutic solutions for infectious diseases. Its platform combines live-attenuated virus design with codon deoptimization, a synthetic biology approach used to engineer viruses with precise, stable changes to their genomes. The company says this method aims to preserve the broad immunity associated with live-attenuated viruses while improving safety, speed, and scalability. Codagenix positions its work as a way to address major global health threats through a new generation of live vaccines.
The company’s activities include research and development across a pipeline of viral vaccine candidates. Publicized projects include work with VaxThera to advance a next-generation yellow fever vaccine and a PATH subcontract to develop stabilized novel oral polio vaccine candidates. Codagenix also shares scientific publications and company news, and invites people interested in advancing global health to explore career opportunities. Its website provides information about its scientific approach, development pipeline, team, and research. Codagenix’s work centers on applying virus-engineering methods to infectious disease challenges, with the goal of creating adaptable vaccine solutions.
Company type
Privately Held
Year founded
2011
Company size
11-50 employees
The Codagenix name, logos and brand assets are trademarks of Codagenix and its affiliates. Brandfetch isn't affiliated with or endorsed by Codagenix. Their use is subject to Codagenix's brand guidelines.
